Search

Author/Creator Yap, Michelle

1. 6 Pre-clinical pharmacodynamic biomarker assays of immune modulation can translate to inform exploratory endpoints of target engagement in first-in-human clinical trial stages of drug discovery. (10th December 2020)

Authors:
Garland, Russell; Kirkham, Christopher; Yap, Michelle; Brackenbury, Louise; Iannitti, Tommaso; Nunan, Robert; Jenkinson, S
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A3
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 6 Pre-clinical pharmacodynamic biomarker assays of immune modulation can translate to inform exploratory endpoints of target engagement in first-in-human clinical trial stages of drug discovery. (9th November 2020)

Authors:
Garland, Russell; Kirkham, Christopher; Yap, Michelle; Brackenbury, Louise; Iannitti, Tommaso; Nunan, Robert; Jenkinson, S
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A6
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Site‐directed mutagenesis of HLA molecules reveals the functional epitope of a human HLA‐A1/A36‐specific monoclonal antibody. (25th November 2022)

Authors:
Meng, Tina; Bezstarosti, Suzanne; Singh, Ujjwala; Yap, Michelle; Scott, Laura; Petrosyan, Naiiry; Quiroz, Fred; Eps, Ned Van; Hui, Eric Ka‐Wai; Suh, David; Zhu, Quansheng; Pei, Rui; Kramer, Cynthia S. M.; Claas, Frans H. J.; Lowe, David; Heidt, Sebastiaan
Journal:
HLA
Issue:
Volume 101:Number 2(2023)
Page Start:
138
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗